Related Experiment Videos
Early detection of relapse in panic disorder
1Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA. mrm6@cwru.edu
Acta Psychiatrica Scandinavica
|October 2, 2004
Summary
Generalized anxiety and disability predict relapse in panic disorder patients discontinuing antidepressants. Early symptom changes can forecast relapse risk, aiding timely intervention for panic disorder management.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Panic disorder is a debilitating condition often treated with serotonergic antidepressants.
- Discontinuation of antidepressants can lead to relapse, necessitating predictive models for early intervention.
- Understanding relapse predictors is crucial for managing panic disorder during antidepressant withdrawal.
Purpose of the Study:
- To develop predictive models for relapse in panic disorder patients after antidepressant discontinuation.
- To identify specific symptom changes that predict relapse during remission.
- To assess the accuracy of predictive models in forecasting panic disorder relapse.
Main Methods:
- A cohort of 47 panic disorder patients undergoing antidepressant discontinuation were studied.
- Data were collected at four time points: pretreatment, randomization, pre-relapse assessment, and final assessment.
- Descriptive statistics, growth curve analysis, and logistic regression were employed to analyze relapse predictors.
Main Results:
- Measures of generalized anxiety, fearfulness, and work/home disability were significant predictors of relapse.
- These general variables outperformed panic and anxiety sensitivity measures in predicting relapse.
- Logistic regression models incorporating these variables achieved 78.7-84.4% accuracy in predicting relapse.
Conclusions:
- Predicting relapse in panic disorder patients discontinuing antidepressants is feasible with fair accuracy.
- Generalized anxiety and disability measures are key indicators of impending relapse.
- These findings enable early identification of patients at risk for relapse, facilitating timely clinical management.